A new mouse model may be critical for understanding the most aggressive types of pancreatic cancer and finding ways to prevent its growth and recurrence.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Editor's Note: Wafaa El-Sadr is executive vice president for Columbia Global and the founder and director of ICAP at the Mailman School of Public Health.
A newly developed prediction model may be able to calculate the risk of opioid relapse among individuals in the early stages of medication treatment—as early as three weeks into therapy.
“If you’re worrying about putting food on the table, your prenatal care appointment isn't going to be your top priority,” said Rebecca Carlin, assistant professor of pediatrics at Columbia University.
As part of a new NIH consortium, scientists will trace how regions targeted by deep brain stimulation connect with the rest of the brain, information that could improve the treatment's efficacy.
Humans evolved to resist losing body fat so that we don’t become extinct, says Rudolph Leibel, chief of the pediatric molecular genetics division at Columbia University’s medical center.
